$27.48
4.73%
NYSE, Sep 17, 04:00 pm EDT. Closed.
ISIN
CA98985W1023
Symbol
ZYME

Zymeworks Inc. Target price 2026 - Analyst rating & recommendation

Zymeworks Inc. Classifications & Recommendation

Buy
94%
Hold
6%

Zymeworks Inc. Price Target

Target Price $39.78
Price $27.48
Potential
Number of Estimates 14
14 Analysts have issued a price target Zymeworks Inc. 2027 . The average Zymeworks Inc. target price is $39.78. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 18 analysts: 17 Analysts recommend Zymeworks Inc. to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Zymeworks Inc. stock has an average upside potential 2027 of . Most analysts recommend the Zymeworks Inc. stock at Purchase.

Sales and Margin forecast 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Revenue Million $ 105.97 321.98
38.89% 203.84%
EBITDA Margin -80.04% 24.38%
45.05% 130.46%
Net Margin -76.56% 33.14%
52.39% 143.29%

14 Analysts have issued a sales forecast Zymeworks Inc. 2026 . The average Zymeworks Inc. sales estimate is

$322m
unlock
. This is
767.17% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$412m 1,008.67%
unlock
, the lowest is
$269m 624.78%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 $106m 38.89%
2026
$322m 203.84%
unlock
2027
$283m 12.12%
unlock
2028
$205m 27.71%
unlock
2029
$359m 75.35%
unlock
2030
$480m 33.85%
unlock
2031
$664m 38.32%
unlock
2032
$728m 9.61%
unlock
2033
$666m 8.54%
unlock

4 Analysts have issued an Zymeworks Inc. EBITDA forecast 2026. The average Zymeworks Inc. EBITDA estimate is

$78.5m
unlock
. This is
152.10% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$82.8m 154.98%
unlock
, the lowest is
$73.5m 148.79%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 $-84.8m 23.68%
2026
$78.5m 192.53%
unlock
2027
$112m 43.14%
unlock
2028
$101m 10.04%
unlock

EBITDA Margin

2025 -80.04% 45.05%
2026
24.38% 130.46%
unlock
2027
39.70% 62.84%
unlock
2028
49.40% 24.43%
unlock

15 Zymeworks Inc. Analysts have issued a net profit forecast 2026. The average Zymeworks Inc. net profit estimate is

$107m
unlock
. This is
171.14% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$191m 227.45%
unlock
, the lowest is
$61.4m 140.90%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 $-81.1m 33.88%
2026
$107m 231.52%
unlock
2027
$97.1m 8.96%
unlock
2028
$9.8m 89.95%
unlock
2029
$79.3m 712.19%
unlock
2030
$80.7m 1.85%
unlock
2031
$81.5m 0.90%
unlock
2032
$82.2m 0.91%
unlock
2033
$82.9m 0.89%
unlock

Net Margin

2025 -76.56% 52.39%
2026
33.14% 143.29%
unlock
2027
34.33% 3.59%
unlock
2028
4.77% 86.11%
unlock
2029
22.10% 363.31%
unlock
2030
16.82% 23.89%
unlock
2031
12.27% 27.05%
unlock
2032
11.29% 7.99%
unlock
2033
12.46% 10.36%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Earnings Per Share $ -1.08 1.48
33.33% 237.04%
P/E 17.70
EV/Sales 5.73

15 Analysts have issued a Zymeworks Inc. forecast for earnings per share. The average Zymeworks Inc. EPS is

$1.48
unlock
. This is
172.20% higher
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
$2.66 229.76%
unlock
, the lowest is
$0.85 141.46%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $-1.08 33.33%
2026
$1.48 237.04%
unlock
2027
$1.35 8.78%
unlock
2028
$0.14 89.63%
unlock
2029
$1.10 685.71%
unlock
2030
$1.12 1.82%
unlock
2031
$1.13 0.89%
unlock
2032
$1.14 0.88%
unlock
2033
$1.15 0.88%
unlock

P/E ratio

Current -13.40 19.09%
2026
17.70 238.28%
unlock
2027
19.44 9.83%
unlock
2028
193.42 894.96%
unlock
2029
23.82 87.68%
unlock
2030
23.39 1.81%
unlock
2031
23.18 0.90%
unlock
2032
22.97 0.91%
unlock
2033
22.77 0.87%
unlock

Based on analysts' sales estimates for 2026, the Zymeworks Inc. stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 49.66
2026
5.73 88.47%
unlock
2027
6.52 13.78%
unlock
2028
9.01 38.32%
unlock
2029
5.14 42.97%
unlock
2030
3.84 25.29%
unlock
2031
2.78 27.70%
unlock
2032
2.53 8.77%
unlock
2033
2.77 9.34%
unlock

P/S ratio

Current
2026
5.78 88.47%
unlock
2027
6.58 13.79%
unlock
2028
9.10 38.32%
unlock
2029
5.19 42.97%
unlock
2030
3.88 25.29%
unlock
2031
2.80 27.70%
unlock
2032
2.56 8.77%
unlock
2033
2.80 9.33%
unlock

Current Zymeworks Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
JP Morgan
Locked
Locked
Locked Sep 03 2026
Citizens
Locked
Locked
Locked Aug 26 2026
Citigroup
Locked
Locked
Locked Aug 26 2026
HC Wainwright & Co.
Locked
Locked
Locked Aug 26 2026
B. Riley Securities
Locked
Locked
Locked Aug 10 2026
Truist Securities
Locked
Locked
Locked Aug 07 2026
Wells Fargo
Locked
Locked
Locked Aug 07 2026
Analyst Rating Date
Locked
JP Morgan:
Locked
Locked
Sep 03 2026
Locked
Citizens:
Locked
Locked
Aug 26 2026
Locked
Citigroup:
Locked
Locked
Aug 26 2026
Locked
HC Wainwright & Co.:
Locked
Locked
Aug 26 2026
Locked
B. Riley Securities:
Locked
Locked
Aug 10 2026
Locked
Truist Securities:
Locked
Locked
Aug 07 2026
Locked
Wells Fargo:
Locked
Locked
Aug 07 2026

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today